.png)
Maximize the potential of your practice with this course. Topics of importance in this course include the clinical indications along with contraindications for IV moderate sedation in the dental environment. Further emphasis on proper patient assessment in the preoperative phase to best evaluate patient suitability and proper patient selection for IV moderate sedation. The course will press the importance of patient assessment and patient evaluation in the operative and post-operative phases including assessment for discharge. Participants will learn to both identify and manage potential adverse reactions and events. Participants will also be taught the pharmacology of relevant medications along with risk-mitigating techniques. Technical airway management skills will be assessed clinically along with infection control and clinical decision making/ sedation management.
All clinical assessments must be graded at least as satisfactory for completion of course. The course will also have 2 multiple choice exams which must be graded at least 80% for completion of the course. One retake per exam is allowed.
Day 1 - 3: 8:30am - 8:30pm
Day 4 - 5 (Acls): 9am - 5pm
Day 6 - 10: 9am - end of clinical experience (expect to run late, some days may end around 11pm)
Day 1
Day 2
Holiday Inn, Mississauga, 100 Brittania Rd. E, Mississauga ON, L4Z 2G1
Day 3
Holiday Inn, Mississauga, 100 Brittania Rd. E, Mississauga ON, L4Z 2G1
Day 6
The Tooth Corner (Central Parkway Mall) 377 Burnhamthorpe Rd. E, Mississauga, ON, L5A3Y1
Day 7 - 10
The Tooth Corner (Central Parkway Mall) 377 Burnhamthorpe Rd. E, Mississauga, ON, L5A3Y1
Winter - January 31st - February 9th, 2024
Spring - April 24th - May 3rd, 2024
Summer - July 3rd - 12th, 2024
Autumn - September 18th - 27th, 2024
Those who have Authorization from the RCDSO
To full-fill the new standards of practice from Nov 2018 RCDSO required training;
This course is catered for Ontario dentists. We have Ontario certified specialists as our instructors. We have emphasis on requirements, certification processes, and sedation techniques that are the standards for the RCDSO.
First 3 days are lecture heavy, with relevant seminar in hotel conference room
Next 2 days are ACLS training in a designated training center
Next day is lecture with heavy seminar participation in a clinical setting
Last 4 days are active IV moderate sedation administration on live patients with interjected case-base seminars and lecture
Breakfast and Lunch are included
Course-end dinner and lounge social event with instructors
In keeping with RCDSO standards we train participants on Midazolam IV moderate sedation
With successful completion of the course, you will not only receive 90 Core 2 CE hours but also receive specific certification of completion from the course director to use in your application.
No. You must have authorization from RCDSO to provide IV moderate sedation.
You will have to apply for authorization with RCDSO which requires:
Part of completing application is to designate if you are applying for Visiting or non-visiting permit. Non-visiting means the provider will not bring equipment with them and it will be provided by the facility.
You must also designate at which facility IV moderate sedation will be performed. This is because regardless of having a visiting or non-visiting IV moderate sedation authorization permit, the facility where the sedation is to occur must also have a facility permit. This is either a A(P1 or greater) permit or B permit. B permits facility have very limited equipment as a visiting provider brings nearly all drugs and equipment with them. The more common Type A permit is for a facility which houses all the sedation equipment and drugs and this is where a non-visiting authorization permit holder would likely work.
Disclaimer: J.A.D.E. (Jai's Academy for Dental Education) is not affiliated, associated, endorsed, or authorized in any way by the National Dental Examination Board of Canada (NDEB). Test names and other trademarks such as 'NDEB', 'BNED', logos or design of the NDEB are the sole properties of the NDEB and not trademarks of the J.A.D.E group.